Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
SIGA Technologies
SIGA
$235M
| $525K | ﹤0.01% |
77,812
-381
| -0.5% | -$3.33K |
|
3652
Nano X Imaging
NNOX
$68.2M
| $524K | ﹤0.01% |
86,181
+62,140
| +258% | +$441K |
|
3653
ENI
E
$80.5B
| $522K | ﹤0.01% |
17,207
-3,987
| -19% | -$125K |
|
3654
Tenaya Therapeutics
TNYA
$161M
| $520K | ﹤0.01% |
269,464
-4,022
| -1% | -$11.4K |
|
3655
Design Therapeutics
DSGN
$761M
| $520K | ﹤0.01% |
96,635
+24,602
| +34% | +$116K |
|
3656
Ramaco Resources Class A
METC
$599M
| $520K | ﹤0.01% |
45,901
+36,128
| +370% | +$431K |
|
3657
Carter Bankshares
CARE
$766M
| $518K | ﹤0.01% |
29,813
+21,457
| +257% | +$353K |
|
|
SNBR
3658
DELISTED
Sleep Number
SNBR
| $518K | ﹤0.01% |
28,280
+20,769
| +277% | +$272K |
|
3659
Camtek
CAMT
$6.18B
| $518K | ﹤0.01% |
6,483
+5,562
| +604% | +$542K |
|
3660
Lands' End
LE
$370M
| $517K | ﹤0.01% |
29,940
+13,520
| +82% | +$210K |
|
3661
Bowman Consulting
BWMN
$470M
| $514K | ﹤0.01% |
21,341
+14,466
| +210% | +$400K |
|
3662
Sprott Physical Silver Trust
PSLV
$12B
| $514K | ﹤0.01% |
49,156
| – | – |
|
3663
Consolidated Water Co
CWCO
$467M
| $513K | ﹤0.01% |
20,350
+15,116
| +289% | +$403K |
|
3664
Taysha Gene Therapies
TSHA
$1.68B
| $512K | ﹤0.01% |
247,280
+193,046
| +356% | +$424K |
|
|
ZH
3665
Zhihu
ZH
$281M
| $511K | ﹤0.01% |
+132,800
| New | +$428K |
|
|
ESPR
3666
DELISTED
Esperion Therapeutics
ESPR
| $511K | ﹤0.01% |
309,671
+154,509
| +100% | +$312K |
|
3667
Meridian
MRBK
$234M
| $511K | ﹤0.01% |
40,406
+3,675
| +10% | +$41.9K |
|
3668
ATS Corp
ATS
$2.64B
| $510K | ﹤0.01% |
+17,567
| New | +$508K |
|
3669
Greif Class B
GEF.B
$4.11B
| $509K | ﹤0.01% |
7,294
+5,330
| +271% | +$352K |
|
3670
LifeVantage
LFVN
$81.1M
| $507K | ﹤0.01% |
41,966
+11,608
| +38% | +$96.1K |
|
3671
Investar Holding Corp
ISTR
$415M
| $507K | ﹤0.01% |
26,122
+5,224
| +25% | +$91.9K |
|
|
AZUL
3672
DELISTED
Azul
AZUL
| $506K | ﹤0.01% |
147,000
+128,400
| +690% | +$483K |
|
3673
SmartRent
SMRT
$195M
| $505K | ﹤0.01% |
292,017
+221,998
| +317% | +$421K |
|
3674
CALL
EOG Resources
EOG
$79.2B
| $504K | ﹤0.01% |
4,100
-57,200
| -93% | -$7.18M |
|
3675
Heritage Insurance Holdings
HRTG
$889M
| $503K | ﹤0.01% |
41,135
-9,745
| -19% | -$113K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.